News

Enhancing Evidence Management: DistillerSR and CCC Alliance

Enhancing Evidence Management: DistillerSR and CCC Alliance

Enhancing Evidence Management: DistillerSR and CCC Alliance

DistillerSR customers can now search for and purchase content directly from CCC's proprietary bibliographic database of more than 165 million articles.

DistillerSR Inc., the leading provider of literature review automation software, has made a significant advancement by partnering with CCC to enable users to order and access scholarly journal articles through the RightFind Enterprise platform. This strategic collaboration aims to streamline the process, allowing users to integrate content procurement directly within their existing workflows.

Integration Benefits for Users

The integration with RightFind Enterprise simplifies the tasks associated with obtaining non-subscribed scientific literature. By eliminating the need for systematic review teams to navigate multiple systems and websites, it enhances efficiency and saves valuable time. Users can swiftly order, pay for, and consolidate payment records, all from a single platform.

Co-Presentation at the Evidence Matters Summit

Both companies are set to co-present this integration at the Evidence Matters Summit, showcasing its capabilities to the user community and highlighting how it optimizes the literature review process.

Streamlined Access to Relevant Research

Peter O'Blenis, CEO of DistillerSR, expressed the company's enthusiasm about this partnership, emphasizing that timely access to RightFind content will significantly reduce the time needed to process literature and synthesize evidence for reviews. This effort aims to lower review costs and expedite the development of medical products and healthcare guidelines.

Key Features of RightFind Enterprise

RightFind Enterprise serves as a part of CCC's RightFind Suite, a robust suite of integrated software modules that empowers professionals in R&D-focused companies to manage, share, and analyze content. This integration takes advantage of the existing collaboration between RightFind and DistillerSR, enabling users to efficiently retrieve bibliographic content while leveraging DistillerSR’s validated workflow, which can decrease literature review timelines by up to 70%.

Expert Insights on Current Research Needs

The importance of accessing reputable and trustworthy information is underscored by Lauren Tulloch, Vice President and Managing Director at CCC. She notes that the expanded integration of RightFind Enterprise with DistillerSR is vital for helping researchers secure the necessary information and accelerate their innovation processes.

CCC plays a crucial role in assisting organizations in managing extensive amounts of published and proprietary data. Their expertise in sourcing data from diverse industries benefits numerous companies, enhancing content discoverability and processing capabilities.

About DistillerSR's Evidence Management Platform

DistillerSR’s evidence management platform is designed to facilitate the automated collection, reuse, and analysis of literature research, offering a fast, accurate, and transparent approach at scale. Since its inception in 2016, DistillerSR has become a trusted name among over 260 leading research organizations worldwide, including major pharmaceutical and medical device companies.

The Future of Research and Evidence Gathering

As healthcare researchers increasingly rely on DistillerSR to automate their literature review processes, they can make better-informing decisions regarding health policy, clinical guidelines, and regulatory submissions. This not only enhances their overall research but improves the pace of innovation in the medical field.

About DistillerSR Inc.
For information and further details, visit www.distillersr.com.

About CCC
CCC is committed to advancing copyright, enhancing knowledge, and driving innovation through comprehensive and flexible solutions in copyright management and data analytics.

DistillerSR Inc. Media Contact
Chris Wright
(613) 212-0051

Frequently Asked Questions

What is the significance of the DistillerSR and CCC collaboration?

This partnership aims to improve access to scientific literature, enhancing the efficiency of literature reviews for researchers.

How does the integration with RightFind Enterprise benefit users?

It simplifies the ordering process for scholarly articles, allowing users to manage tasks within a single platform without the need to log into multiple systems.

What features does RightFind Enterprise provide?

RightFind Enterprise includes modules that enable searching, sharing, and analyzing scientific content, designed for R&D-focused companies.

How has DistillerSR impacted literature reviews?

DistillerSR has been instrumental in reducing literature review times by as much as 70%, increasing efficiency and transparency in the process.

Who can benefit from using DistillerSR?

Over 260 leading research organizations, including major pharmaceutical and medical device companies, rely on DistillerSR to streamline their literature review processes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 74

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 186

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 193

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 255

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 129

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 372

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 203

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 115

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading

Top 5 Most Recently Viewed Articles

AngioDynamics' NanoKnife® System Receives FDA Clearance

Updated Category News Views 191

Introduction to AngioDynamics' Innovation AngioDynamics, Inc. (NASDAQ: ANGO), a forward-thinking medical technology firm, has made significant strides in restoring healthy blood flow and enhancing cancer treatment options. Recently, the company announced its accomplishment in receiving FDA 510(k) clearance for its advanced NanoKnife System, specifically designed for...

Continue Reading
Analyst Predicts iPhone Dominance in Apple's Future Revenues

Updated Category News Views 197

Apple's Revenue Outlook and iPhone Influence A recent analysis by Needham paints a promising picture for Apple Inc (NASDAQ: AAPL) as the company prepares for fiscal year 2025. Analyst Laura Martin affirmed a buy rating for Apple, setting an impressive price target of $260. This forecast is based on a well-crafted Discounted Cash Flow (DCF) model, which includes a cash tax...

Continue Reading
Sitetracker's Record Growth and Vision for Future Success

Updated Category News Views 398

Remarkable Achievements in 2024 for Sitetracker Sitetracker has reached significant milestones marking the close of its fiscal year with outstanding growth and exciting plans for the upcoming year. As a leader in the field of asset lifecycle management, they have positioned themselves strongly in markets worldwide, focusing on providing tools for various critical...

Continue Reading
Olympus Showcases Innovative ENT Solutions at Major Meetings

Updated Category News Views 176

Olympus Highlights Cutting-Edge ENT Solutions Olympus Corporation of the Americas, a leading medical technology company committed to enhancing health and safety, will unveil its extensive ENT portfolio at upcoming annual physician meetings. Attendees will have the opportunity to see how Olympus integrates hybrid endoscopy with advanced imaging and content management...

Continue Reading
Exciting Launch of Tech Mahindra Chess League Season 3

Updated Category News Views 101

Tech Mahindra Global Chess League Season 3 Launches with Excitement The Global Chess League (GCL) has officially begun its Season 3, and excitement fills the air as six teams are set to compete in 34 matches for the coveted championship trophy. The league kicked off at Mumbai's Royal Opera House, a perfect venue for this grand event. Spectacular Opening Ceremony in Mumbai...

Continue Reading